#Japan #Tokyo #Rosetta #AI in Pharma #Pharmaceutical DX

Unlocking the Future of Pharmaceutical Digital Transformation with AI

As the pharmaceutical industry rapidly evolves, companies grapple with challenges like discovering new drug targets, reducing research and development timelines, and maximizing the use of data. Amidst this landscape, AI is fundamentally reshaping how the sector operates. To illuminate these changes, Rosetta Inc., led by President Junichi Goishi, will be hosting a free online seminar titled "Unlocking the Future of Pharmaceutical DX: Learning Success Rules and Pitfalls from Global AI Case Studies", scheduled for September 10th and September 18th, 2025, at 12:00 PM (JST).

Target Audience

This webinar is ideally suited for those who:

• - Are interested in improving research and development processes through AI integration.
• - Are exploring new approaches for drug discovery and development practices.
• - Wish to gather insights from advanced case studies in international pharmaceutical companies to inform their AI strategies.
• - Seek to accelerate their digital transformation (DX) initiatives but are uncertain about where to begin.

Seminar Overview

This engaging session will delve into two key themes:
1. Latest Trends in Generative AI for Pharmaceutical Industry: Participants will catch up on the leading-edge developments shaping the pharmaceutical landscape with AI.
2. Breakthroughs in Drug Discovery and Genomic Analysis: Real case studies will demonstrate how AI is revolutionizing research and development processes.
3. Effective AI Implementation Tips: Learn from global success and failure stories to avoid common pitfalls in AI adoption within the industry.

The agenda may shift depending on circumstances, ensuring that content remains timely and relevant.

Event Details

• - Dates:

- Session 1: September 10, 2025, from 12:00 to 13:00 (JST)
- Session 2: September 18, 2025, from 12:00 to 13:00 (JST)
(Both sessions will cover the same content)

• - Format: Online via Microsoft Teams
• - Speaker: Makoto Miyoshi, Chief Strategy Officer at Metarial Inc., will share insights from his extensive experience in AI deployment within the Southeast Asian market.
• - Cost: Free admission

How to Register

Interested attendees can register for each session via the following links:

• - Register for September 10th
• - Register for September 18th

About the Speaker: Makoto Miyoshi

Makoto Miyoshi is a seasoned professional in AI utilization, having started an entrepreneurial journey during his time at Keio University. After venturing into consulting with Deloitte, aiding global strategies, and later working with Google to facilitate market growth in the Asia Pacific and North America, he now serves as the Chief Strategy Officer at Metarial. His broad expertise spans recruitment, M&A, business development, and organizational strategies.

About Metarial Group

Metarial Group aims to free people from constraints of location, time, and language. With a leading position in the translation market, they excel in developing customized AI solutions across various sectors, including legal, pharmaceuticals, finance, and technology. Their innovative AI systems like translation AI, financial report AI, and specialized AI translation services are pushing boundaries in how information is processed and delivered.

For more on their innovative AI solutions and services, visit their official site.

About Rosetta Inc.

As a pioneer in AI translation, Rosetta leverages experience gained from over 6,000 clients to cater to specialized document creation across various industries. Their flagship services, such as high-precision AI translation, exemplify their commitment to excellence.

For further inquiries, contact: [email protected].